Follow-on roundup: Ascendis, Sarepta

Ascendis and Sarepta each priced follow-ons, raising $500 million and $375 million, respectively, after the bell Tuesday. Invitae and CymaBay also priced follow-ons.

Ascendis Pharma A/S (NASDAQ:ASND) raised $500 million through the sale of 4.2 million ADSs at $120. The price is a slight discount to its Monday close of $120.60, when Ascendis proposed the offering after market close. The company lost $10.70 to $114.70 on Wednesday...